Barclays PLC Trims Stake in ICU Medical, Inc. (NASDAQ:ICUI)

Barclays PLC cut its stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 15.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 50,081 shares of the medical instruments supplier's stock after selling 9,126 shares during the period. Barclays PLC owned 0.20% of ICU Medical worth $7,771,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. Franklin Resources Inc. lifted its position in ICU Medical by 99.3% during the 3rd quarter. Franklin Resources Inc. now owns 11,708 shares of the medical instruments supplier's stock worth $2,111,000 after acquiring an additional 5,834 shares during the period. Principal Financial Group Inc. increased its holdings in ICU Medical by 24.6% in the 3rd quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier's stock worth $23,130,000 after buying an additional 25,031 shares during the period. Diversified Trust Co lifted its stake in ICU Medical by 32.3% during the 4th quarter. Diversified Trust Co now owns 3,301 shares of the medical instruments supplier's stock valued at $512,000 after acquiring an additional 805 shares during the period. Inspire Investing LLC increased its stake in shares of ICU Medical by 13.2% in the fourth quarter. Inspire Investing LLC now owns 2,601 shares of the medical instruments supplier's stock worth $404,000 after acquiring an additional 303 shares during the period. Finally, KBC Group NV lifted its position in ICU Medical by 2,498.0% during the fourth quarter. KBC Group NV now owns 17,303 shares of the medical instruments supplier's stock valued at $2,685,000 after purchasing an additional 16,637 shares during the period. Institutional investors and hedge funds own 96.10% of the company's stock.

ICU Medical Price Performance

Shares of NASDAQ:ICUI traded down $1.50 during trading on Friday, reaching $135.66. The stock had a trading volume of 164,550 shares, compared to its average volume of 274,007. The stock has a market cap of $3.34 billion, a PE ratio of -29.68 and a beta of 0.86. ICU Medical, Inc. has a 1-year low of $95.44 and a 1-year high of $196.26. The business has a fifty day moving average price of $143.81 and a 200-day moving average price of $158.07. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.

Wall Street Analysts Forecast Growth

ICUI has been the subject of a number of recent research reports. Raymond James set a $97.00 price objective on ICU Medical in a research note on Wednesday, March 12th. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a research note on Tuesday, April 8th. KeyCorp cut their price objective on shares of ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a report on Monday, April 21st. Finally, StockNews.com lowered shares of ICU Medical from a "buy" rating to a "hold" rating in a research note on Thursday. Two equities research analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, ICU Medical currently has a consensus rating of "Moderate Buy" and a consensus target price of $162.67.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.